May 29, 2026 - 00:56

Swiss biotech firm VERAXA Biotech AG has secured a significant financial commitment as it prepares to list on the Nasdaq. The company announced it has entered into a securities purchase agreement with an institutional investor for $27.5 million. This new funding is separate from an existing $50 million share purchase agreement the company already holds with Lincoln Park Capital Fund.
Alongside the financing, VERAXA has applied to list its shares on the Nasdaq under the ticker symbol "VRXA." The company plans to achieve this listing through a business combination with Voyager Acquisition Corp., a special purpose acquisition company. The move is expected to provide VERAXA with the capital and public market access needed to advance its pipeline of therapies.
The company is focused on developing treatments for diseases with high unmet medical needs. The combined funding from the institutional investor and the Lincoln Park agreement is intended to support clinical development and operational growth. The deal with Voyager is subject to customary closing conditions and approvals.
May 28, 2026 - 00:44
Trend shows Gen Z, younger millennials investing earlier in the stock marketA San Diego teenager has taken it upon himself to teach classmates about stocks and financial literacy, reflecting a broader trend where Gen Z and younger millennials are starting to invest at much...
May 27, 2026 - 05:53
Superlong JGB Yields Rise on Expectations for Higher InflationSuperlong Japanese government bond yields moved higher on Monday, driven by persistent market expectations that rising oil prices will push inflation upward. Investors are pricing in the likelihood...
May 26, 2026 - 17:25
Are microvacations the trick for getting away on a budget?The idea of a grand, two-week vacation is appealing, but for many people, the cost and the time off required make it feel out of reach. Enter the microvacation. These are short getaways, often...
May 26, 2026 - 04:11
Asian Equities, Oil Prices Mixed as Investors Parse Middle East DevelopmentsAsian equity markets and crude oil prices traded in conflicting directions on Tuesday as investors weighed the latest developments in the Middle East. The U.S. military launched strikes against...